Evaluating the effects of crystallinity in new biocompatible polyester nanocarriers on drug release behavior
Vassilios Karavelidis1,2, Evangelos Karavas2, Dimitrios Giliopoulos1, Sofia Papadimitriou1, Dimitrios Bikiaris11Laboratory of Polymer Chemistry and Technology, Chemistry Department, Aristotle University of Thessaloniki, Thessaloniki, 2Pharmathen SA, Pharmaceutical Industry, Pallini Attikis, Attiki,...
Guardado en:
Autores principales: | Karavelidis V, Karavas E, Giliopoulos D, Papadimitriou S, Bikiaris D |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ae0dfc55c9f246b1b0f574154b1e6ae6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effective Oxidation-Responsive Polyester Nanocarriers for Anti-Inflammatory Drug Delivery
por: He P, et al.
Publicado: (2021) -
Folate and Pegylated Aliphatic Polyester Nanoparticles for Targeted Anticancer Drug Delivery
por: Tsolou A, et al.
Publicado: (2020) -
Synthesis of biocompatible poly(ε-caprolactone)-block-poly(propylene adipate) copolymers appropriate for drug nanoencapsulation in the form of core-shell nanoparticles
por: Nanaki SG, et al.
Publicado: (2011) -
Genetically engineered nanocarriers for drug delivery
por: Shi P, et al.
Publicado: (2014) -
Physicochemical characterization of drug nanocarriers
por: Manaia EB, et al.
Publicado: (2017)